NHS
Sanofi prostate cancer drug to remain on CDF
May 26, 2015Sales and Marketing CDF, Cancer, NHS, Sanofi, list, prostate
Sanofi has reached an agreement with NHS England to reinstate its prostate cancer drug Jevtana on the Cancer Drugs Fund. …
Bayer wins Cancer Drugs Fund appeal
May 22, 2015Sales and Marketing Bayer, CDF, Cancer Drugs Fund, Eisai, NHS, lilly
Bayer is the only company to win its appeal to NHS England in the latest round of Cancer Drugs Fund …
NHS online starting to take shape
May 20, 2015Medical Communications, Sales and Marketing HSCIC, NHS, brett wells, nhs online
In England over 55 million patients can now order repeat prescriptions, book GP appointments and access their medical records online …
Cameron restates £8 billion NHS funding plans
May 18, 2015Sales and Marketing BMA, Cameron, NHS, UK
UK prime minister David Cameron has committed to extra funding for the NHS in his first major speech following the …
UK doctors urged to curb overtreatment
May 13, 2015Sales and Marketing Academy of Medical Royal Colleges, BMJ, NHS, uk doctors
The UK’s body of medical colleges has launched a new campaign to warn of the dangers of over-treating patients with …
Scottish Medicines Consortium approves seven drugs
May 12, 2015Sales and Marketing NHS, SMC, Scottish Medicines Consortium
The Scottish Medicines Consortium has accepted seven new medicines and indications for use on the NHS in Scotland. Two of …
NHS ‘close to breaking point’
April 30, 2015Medical Communications, Sales and Marketing BMJ, Godlee, Kings Fund, NHS, king's fund
England’s NHS is ‘stretched close to breaking point’ and the next five years are likely to be the most challenging …
Pharma accused of hiding behind regulation and undermining NICE
April 29, 2015Medical Communications, Sales and Marketing NHS, NICE, Royal Society of Medicine, UK, brett wells, health, pharma
University of York health economists have argued that pharma regulation is not evidence-based, lacks accountability and undermines NICE. Writing in …
Trial results back NICE decision on Novartis cancer drug
April 15, 2015Sales and Marketing Arzerra, Cancer, NHS, NICE, chemo, chlorambucil, fludarabine, leukaemia, ofatumumab
Treatment with Arzerra improves survival in people with chronic lymphocytic leukaemia (CLL) according to study results that back NICE’s decision …
E-clinical: the rise of new health technologies
April 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, NHS, apps, digital, eHealth, eyeforpharma, kelsey, pharma, wearables
In the UK the NHS is generally considered to be traditionally resistant to new technology, but it has been forced …
Over one billion drugs dispensed in England in 2014, NHS report shows
April 9, 2015Sales and Marketing HSCIC, NHS, drug cost, net ingredient cost, prescribing, prescription cost analysis, prescriptions
Patients in England collected over 1.1 billion prescription items in 2014, according to NHS figures. Statistics from the Health and …
Novartis accused of Lucentis ‘campaign’ against Avastin
April 2, 2015Sales and Marketing Lucentis, NHS, Novartis, avastin, bevacizumab, ranibizumab, wet AMD
Novartis “embarked on a campaign to undermine and divert attention” from a cheap drug for vision loss and maintain the …
NHS in England is ‘deteriorating’
March 26, 2015Sales and Marketing Conservatives, England, Labour, NHS, coalition, election, government, liberal
Leading UK healthcare think tank The King’s Fund has published its second report on the NHS under the present government …
NICE decisions made on Bayer, Celgene and Boehringer drugs
March 26, 2015Sales and Marketing Bayer, Boehringer, Celgene, NHS, Xarelto, imnovid, jardiance
In final guidance NICE has recommended Bayer’s Xarelto and Boehringer’s Jardiance for NHS funding, but not Celgene’s Imnovid. Bayer’s Xarelto …
NHS launches mental health apps library
March 25, 2015Medical Communications, Sales and Marketing England, NHS, apps, choices, digital, kitemark, online
NHS England has launched a directory of digital services it endorses for the treatment of mental health, in the first …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
